541 related articles for article (PubMed ID: 16010431)
21. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
Takeuchi S; Mori N; Koike M; Slater J; Park S; Miller CW; Miyoshi I; Koeffler HP
Cancer Res; 1996 Feb; 56(4):738-40. PubMed ID: 8631006
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer.
Powell CA; Klares S; O'Connor G; Brody JS
Clin Cancer Res; 1999 Aug; 5(8):2025-34. PubMed ID: 10473082
[TBL] [Abstract][Full Text] [Related]
23. Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma.
Shipman R; Schraml P; Colombi M; Ludwig CU
Int J Oncol; 1998 Jan; 12(1):107-11. PubMed ID: 9454893
[TBL] [Abstract][Full Text] [Related]
24. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
[TBL] [Abstract][Full Text] [Related]
25. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
Hurr K; Kemp B; Silver SA; el-Naggar AK
Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
[TBL] [Abstract][Full Text] [Related]
28. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA
Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771
[TBL] [Abstract][Full Text] [Related]
29. Frequency of loss of heterozygosity at 3 p, 9 p, 13 q, and 17 p is related to proliferative activity in smokers with stage I non-small cell lung cancer.
Haga Y; Hiroshima K; Iyoda A; Kohno H; Shibuya K; Iizasa T; Fujisawa T; Ohwada H
Thorac Cardiovasc Surg; 2005 Apr; 53(2):114-7. PubMed ID: 15786011
[TBL] [Abstract][Full Text] [Related]
30. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.
Crowell RE; Gilliland FD; Temes RT; Harms HJ; Neft RE; Heaphy E; Auckley DH; Crooks LA; Jordan SW; Samet JM; Lechner JF; Belinsky SA
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):631-7. PubMed ID: 8824366
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
32. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
[TBL] [Abstract][Full Text] [Related]
33. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
Kohno H; Hiroshima K; Toyozaki T; Fujisawa T; Ohwada H
Cancer; 1999 Jan; 85(2):341-7. PubMed ID: 10023701
[TBL] [Abstract][Full Text] [Related]
34. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
[TBL] [Abstract][Full Text] [Related]
35. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
Tran YK; Newsham IF
Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
[TBL] [Abstract][Full Text] [Related]
36. Allelic deletion mapping on chromosome 5 in human carcinomas.
Wieland I; Böhm M; Arden KC; Ammermüller T; Bogatz S; Viars CS; Rajewsky MF
Oncogene; 1996 Jan; 12(1):97-102. PubMed ID: 8552404
[TBL] [Abstract][Full Text] [Related]
37. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer.
Fong KM; Kida Y; Zimmerman PV; Ikenaga M; Smith PJ
Cancer Res; 1995 Oct; 55(19):4268-72. PubMed ID: 7671234
[TBL] [Abstract][Full Text] [Related]
39. High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers.
Tai AL; Mak W; Ng PK; Chua DT; Ng MY; Fu L; Chu KK; Fang Y; Qiang Song Y; Chen M; Zhang M; Sham PC; Guan XY
Cancer Res; 2006 Apr; 66(8):4133-8. PubMed ID: 16618734
[TBL] [Abstract][Full Text] [Related]
40. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]